LINE

Text:AAAPrint
Sci-tech

China's drug regulator accepts CanSinoBIO COVID-19 vaccine application

1
2021-02-24 16:35:51CGTN Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

CanSino Biologics Inc (CanSinoBIO) said China's drug regulator, the National Medical Products Administration, accepted its COVID-19 vaccine application on Wednesday.

The single-dose vaccine, developed by CanSinoBIO and a team led by Chen Wei, a researcher from the Beijing-based Academy of Military Medical Sciences, will become the country's third locally developed shot allowed for conditional use by the general public if approved.

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2021 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.